Target intelligence / Profile preview

Epididymal fat immune responses

Molecular classification
Biological process, Cellular response
01

Overview

Epididymal fat immune responses encompass the complex immunological activities and signaling cascades occurring within the epididymal white adipose tissue (eWAT), which serves as a major visceral fat depot in rodent models (Source: PubMed ID 28249854). In lean individuals, this tissue is characterized by homeostatic immune cells, such as M2-polarized macrophages and regulatory T cells, which help maintain insulin sensitivity (Source: Nature Reviews Immunology, 2017). During the development of obesity, the adipose tissue undergoes remodeling, characterized by adipocyte hypertrophy and the recruitment of pro-inflammatory M1-like macrophages and CD8+ T cells (Source: PMC4141561). This transition results in the formation of crown-like structures around dying adipocytes and the chronic secretion of pro-inflammatory cytokines like TNF-α and IL-6. These localized immune responses are a fundamental driver of systemic low-grade inflammation and insulin resistance, linking metabolic excess to chronic diseases like type 2 diabetes (Source: NIH/NIDDK). While "Epididymal fat immune responses" refers to a broad physiological process rather than a specific protein target, many individual components within this response, such as specific cytokine receptors or chemokine pathways, are active areas of therapeutic research.

Other names
Epididymal white adipose tissue (eWAT) inflammationVisceral adipose tissue immune responseAdipose tissue-resident immune cell activationeWAT immune cell infiltration
02

Mechanism of action

Not applicable; this is a complex biological process involving multiple cell types and signaling pathways rather than a single molecular target.

03

Biological functions

Immune responseInflammationMetabolic regulationLipid metabolismCytokine production
04

Disease associations

ObesityType 2 diabetes mellitusInsulin resistanceMetabolic syndromeNon-alcoholic fatty liver disease (NAFLD)
05

Safety considerations

Systemic immunosuppressionImpaired wound healingCompromised host defense against infectionsPotential for metabolic rebound
06

Biomarkers

Adipose tissue macrophages (ATMs)Crown-like structures (CLS)Tumor necrosis factor-alpha (TNF-α)Interleukin-6 (IL-6)Monocyte chemoattractant protein-1 (MCP-1)

Beyond the preview

Go deeper on Epididymal fat immune responses.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Epididymal fat immune responses.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call